rehabilitation

July 2022 Br J Cardiol 2022;29(suppl 2):S13–S16 doi:10.5837/bjc.2022.s08

Guidance on lifestyle, rehabilitation and devices in heart failure patients

Savvas Hadjiphilippou, Rebecca Lane

Abstract

Introduction The 2021 European Society of Cardiology Congress saw the release of an update of the ESC guidelines for the diagnosis and treatment of acute and chronic heart failure (HF).1 This timely and comprehensive new set of guidelines is particularly noteworthy because of its inclusion of the Patient Forum as full members of the task force; a first for ESC HF guidance. HF management programmes Evident within the updated guidance is an emphasis on putting patients at the centre of HF care and empowering them to take ownership of their condition. Since the 2016 ESC HF guidelines2 were published, a growing body of evidence has placed increa

| Full text

June 2016 Br J Cardiol 2016;23:61–4 doi:10.5837/bjc.2016.020

Clinical and psychological outcomes of an angina management programme

Deborah Tinson, Samantha Swartzman, Kate Lang, Sheena Spense, Iain Todd

Abstract

Introduction Chronic refractory angina is defined as coronary insufficiency in the presence of coronary artery disease with clinically established reversible myocardial ischaemia that cannot be controlled by a combination of medical therapy, angioplasty and coronary bypass surgery (CABG).1 Symptom duration should exceed three months. It carries a small increased risk of mortality,2 a significant risk of morbidity3 and accounts for more than 1% of the UK’s total health service budget.4 Triggers for angina include behavioural factors, such as activity and stress. Common misconceptions (e.g. that angina may precipitate myocardial infarction) m

| Full text